Clinical Trial Update: Diabetic Gastroparesis Efficacy/Safety Study of TZP-102 [Phase 2]

View source ↗

Summary

A Phase 2 trial of TZP-102 for diabetic gastroparesis has been terminated. The update notes the study status but does not provide efficacy or safety results in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Gastroparesis

Drugs mentioned

• TZP-102

Snippet

Sponsor: Tranzyme, Inc. | Conditions: Diabetic Gastroparesis | Phase 2 | Status: TERMINATED